Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3,118.00    -31.00 (-0.98%)
Bid:
3,127.00
Ask:
3,129.00
Spread: 2.00 (0.064%)
Market Cap: £4.35b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Q1 2010 Trading Statement

28 Apr 2010 07:00

RNS Number : 9062K
Croda International PLC
28 April 2010
 



28 April 2010

 

Croda International Plc

First quarter trading statement

 

Martin Flower, Chairman of Croda International Plc, is due to provide the following update on first quarter trading at today's Annual General Meeting:

 

"At the time of our preliminary results in February we reported that the strong trading performance seen in the second half of 2009 had continued into 2010. We are now able to report record quarterly sales and profits in both Consumer Care and Industrial Specialities.

 

Group sales increased 14.7% to £264.7m (2009: £230.8m) despite adverse currency translation of 4.1%, with overall volumes increasing 26.0%.

 

Group pre-tax profit from continuing operations almost doubled to £42.4m (2009: £21.7m).

 

On a segmental basis, Consumer Care operating profit was up 20.6% to £34.6m (2009: £28.7m) despite challenging 2009 comparatives. Underlying sales increased strongly in both Personal Care and Health Care but Crop Care sales were down in line with the market. Overall sales increased to £130.0m, up 1.4% on last year's figure of £128.2m, despite the adverse currency translation.

 

Industrial Specialities reversed last year's £2.4m loss to record an operating profit of £10.5m with almost all areas seeing significant revenue and profit increases. Volumes increased dramatically and this is driving the 31% increase in revenues to £134.7m (2009: £102.6m).

 

As a consequence of the cash restructuring costs from the closures of both Bromborough and Wilton and adverse currency translation of £5.8m, net debt was little changed from the year end at £292.7m.

 

This is a very strong performance across the business and reflects both robust demand for our products globally and the benefits of the cost cutting activity we have undertaken since the acquisition of Uniqema. However, the buoyant trading conditions we have experienced have been seen across the chemical sector, suggesting an element of restocking. Furthermore, prior year comparatives do get tougher in the second half. We also expect to see raw material inflation begin to increase in many areas.

 

Notwithstanding the above, the robust trading has continued into quarter two and we remain confident of achieving significant progress throughout the remainder of 2010."

 

 

For further information, please contact:

 

Mike Humphrey, Group Chief Executive

Tel: 01405 860551

Sean Christie, Group Finance Director

Charlie Armitstead, Financial Dynamics

Tel: 07703 330 269

 

The company will host a conference call for analysts at 8.00am (BST) today:

Dial-In: +44 (0)1452 542 303

Please quote "Croda International"to gain access to the call

 

 

Croda International Plc

Unaudited income statement before tax and exceptional items

31 March 2010

£m

3 months to

3 months to

31 March

31 March

2010

2009

Change

Consumer Care

130.0

128.2

+1.4%

Industrial Specialities

134.7

102.6

+31.3%

Revenues from continuing operations

264.7

230.8

+14.7%

Consumer Care

34.6

28.7

+20.6%

Industrial Specialities

10.5

(2.4)

n/a

Operating profit from continuing operations

45.1

26.3

+71.5%

Net bank and loan interest payable

(2.8)

(4.5)

Net retirement benefit scheme financing

0.1

(0.1)

Profit before tax from continuing operations

42.4

21.7

+95.4%

Continuing operations operating margin

17.0%

11.4%

Analysis of turnover uplift for continuing operations

Continuing operations sales volumes

+26.0%

Currency impact

-4.1%

Price/mix

-7.2%

+14.7%

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFRSLIDFII
Date   Source Headline
29th Mar 20227:00 amRNSInvestor seminar
22nd Mar 20226:14 pmRNSAnnual Financial Report
22nd Mar 20224:49 pmRNSDirector/PDMR Shareholding
16th Mar 20225:21 pmRNSDirector/PDMR Shareholding
16th Mar 20225:20 pmRNSDirector/PDMR Shareholding
16th Mar 20225:19 pmRNSDirector/PDMR Shareholding
16th Mar 20225:15 pmRNSDirector/PDMR Shareholding
16th Mar 20225:15 pmRNSDirector/PDMR Shareholding
16th Mar 20225:13 pmRNSDirector/PDMR Shareholding
16th Mar 20225:11 pmRNSDirector/PDMR Shareholding
16th Mar 20225:11 pmRNSDirector/PDMR Shareholding
16th Mar 20225:04 pmRNSDirector/PDMR Shareholding
16th Mar 20225:03 pmRNSDirector/PDMR Shareholding
15th Mar 202211:24 amRNSDirector/PDMR Shareholding
11th Mar 20222:25 pmRNSDirector/PDMR Shareholding
10th Mar 20221:10 pmRNSDirector/PDMR Shareholding
3rd Mar 202211:27 amRNSDirector/PDMR Shareholding
1st Mar 20227:00 amRNSResults for the year ended 31 December 2021
11th Feb 20222:26 pmRNSDirector/PDMR Shareholding
25th Jan 202210:47 amRNSHolding(s) in Company
17th Jan 20222:18 pmRNSHolding(s) in Company
11th Jan 20223:56 pmRNSDirector/PDMR Shareholding
7th Jan 20227:00 amRNSDirectorate Change
6th Jan 20228:41 amRNSDirector Declaration
22nd Dec 20217:36 amRNSAgreement to Sell Majority of PTIC Announcement
13th Dec 20214:23 pmRNSDirector/PDMR Shareholding
22nd Nov 20211:54 pmRNSDirector/PDMR Shareholding
11th Nov 20212:31 pmRNSDirector/PDMR Shareholding
1st Nov 20219:56 amRNSDirector/PDMR Shareholding
1st Nov 20219:52 amRNSDirector/PDMR Shareholding
1st Nov 20219:45 amRNSDirector/PDMR Shareholding
1st Nov 20219:39 amRNSDirector/PDMR Shareholding
1st Nov 20219:37 amRNSDirector/PDMR Shareholding
13th Oct 20212:42 pmRNSDirector/PDMR Shareholding
11th Oct 20215:00 pmRNSDirector/PDMR Shareholding
11th Oct 20212:03 pmRNSDirector/PDMR Shareholding
6th Oct 20212:15 pmRNSDirector/PDMR Shareholding
16th Sep 20215:20 pmRNSDirector/PDMR Shareholding
13th Sep 20212:27 pmRNSDirector/PDMR Shareholding
18th Aug 20217:39 amRNSDirector/PDMR Shareholding
11th Aug 20212:59 pmRNSDirector/PDMR Shareholding
10th Aug 202110:46 amRNSDirector/PDMR Shareholding
4th Aug 202111:49 amRNSDirector/PDMR Shareholding
27th Jul 20217:00 amRNSResults for the six months ended 30 June 2021
23rd Jul 20217:30 amRNSDirectorate Change
13th Jul 20211:58 pmRNSDirector/PDMR Shareholding
9th Jun 20217:39 amRNSDirector Declaration
8th Jun 202110:36 amRNSDirector/PDMR Shareholding
7th Jun 202111:45 amRNSDirector/PDMR Shareholding
4th Jun 20211:13 pmRNSRestatement of results for new reporting structure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.